temoporfin has been researched along with Cancer, Second Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braichotte, D; Fontolliet, C; Mizeret, J; Monnier, P; Savary, JF; van den Bergh, H; Wagnières, G | 1 |
Braichotte, D; Fontolliet, C; Grosjean, P; Monnier, P; Savary, JF; van den Bergh, H; Wagnieres, G | 1 |
2 other study(ies) available for temoporfin and Cancer, Second Primary
Article | Year |
---|---|
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
Topics: Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Evaluation Studies as Topic; Female; Humans; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Mouth Neoplasms; Neoplasms, Second Primary; Photochemotherapy; Radiation-Sensitizing Agents | 1997 |
Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Esophageal Neoplasms; Esophagus; Female; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Humans; Male; Mesoporphyrins; Middle Aged; Necrosis; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome | 1998 |